Ebrahimi, Moein http://orcid.org/0000-0001-6166-1492
Sivaprasad, Sobha
Article History
Received: 5 July 2023
Revised: 27 March 2024
Accepted: 4 April 2024
First Online: 11 April 2024
Competing interests
: SS reported receiving financial support from AbbVie, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, Eyebiotech, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, OcuTerra, Roche. SS is also a member of the <i>Eye</i> editorial board. ME has no conflicts of interest.